123 related articles for article (PubMed ID: 18843266)
1. Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency.
de Diego-Otero Y; Romero-Zerbo Y; el Bekay R; Decara J; Sanchez L; Rodriguez-de Fonseca F; del Arco-Herrera I
Neuropsychopharmacology; 2009 Mar; 34(4):1011-26. PubMed ID: 18843266
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
3. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
[TBL] [Abstract][Full Text] [Related]
4. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
[TBL] [Abstract][Full Text] [Related]
5. Linking the Fragile X mental retardation protein to the lipoxygenase pathway.
Beaulieu MA
Med Hypotheses; 2013 Mar; 80(3):289-91. PubMed ID: 23313071
[TBL] [Abstract][Full Text] [Related]
6. Mouse model of fragile X syndrome: behavioral and hormonal response to stressors.
Nielsen DM; Evans JJ; Derber WJ; Johnston KA; Laudenslager ML; Crnic LS; Maclean KN
Behav Neurosci; 2009 Jun; 123(3):677-86. PubMed ID: 19485574
[TBL] [Abstract][Full Text] [Related]
7. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse model for the fragile X syndrome.
Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
[TBL] [Abstract][Full Text] [Related]
9. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
Qin M; Kang J; Smith CB
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
[TBL] [Abstract][Full Text] [Related]
10. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Yan QJ; Rammal M; Tranfaglia M; Bauchwitz RP
Neuropharmacology; 2005 Dec; 49(7):1053-66. PubMed ID: 16054174
[TBL] [Abstract][Full Text] [Related]
11. Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test.
de Esch CE; van den Berg WE; Buijsen RA; Jaafar IA; Nieuwenhuizen-Bakker IM; Gasparini F; Kushner SA; Willemsen R
Neurobiol Dis; 2015 Mar; 75():31-9. PubMed ID: 25562659
[TBL] [Abstract][Full Text] [Related]
12. Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008).
Brodkin ES
Behav Neurosci; 2008 Apr; 122(2):483-9. PubMed ID: 18410188
[TBL] [Abstract][Full Text] [Related]
13. An Abnormal Nitric Oxide Metabolism Contributes to Brain Oxidative Stress in the Mouse Model for the Fragile X Syndrome, a Possible Role in Intellectual Disability.
Lima-Cabello E; Garcia-Guirado F; Calvo-Medina R; el Bekay R; Perez-Costillas L; Quintero-Navarro C; Sanchez-Salido L; de Diego-Otero Y
Oxid Med Cell Longev; 2016; 2016():8548910. PubMed ID: 26788253
[TBL] [Abstract][Full Text] [Related]
14. NNZ-2566, a novel analog of (1-3) IGF-1, as a potential therapeutic agent for fragile X syndrome.
Deacon RM; Glass L; Snape M; Hurley MJ; Altimiras FJ; Biekofsky RR; Cogram P
Neuromolecular Med; 2015 Mar; 17(1):71-82. PubMed ID: 25613838
[TBL] [Abstract][Full Text] [Related]
15. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.
Baker KB; Wray SP; Ritter R; Mason S; Lanthorn TH; Savelieva KV
Genes Brain Behav; 2010 Aug; 9(6):562-74. PubMed ID: 20398059
[TBL] [Abstract][Full Text] [Related]
16. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
17. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of Autism-associated genes in the brain of Fragile X mouse model.
Zhang A; Shen CH; Ma SY; Ke Y; El Idrissi A
Biochem Biophys Res Commun; 2009 Feb; 379(4):920-3. PubMed ID: 19138667
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.
Heulens I; D'Hulst C; Van Dam D; De Deyn PP; Kooy RF
Behav Brain Res; 2012 Apr; 229(1):244-9. PubMed ID: 22285772
[TBL] [Abstract][Full Text] [Related]
20. Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome.
Wang X; Snape M; Klann E; Stone JG; Singh A; Petersen RB; Castellani RJ; Casadesus G; Smith MA; Zhu X
J Neurochem; 2012 May; 121(4):672-9. PubMed ID: 22393900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]